Likewise, glioma cell lines, GBM xenografts and patient tumor samples bearing somatic mutations in MSH2, MLH1 and MSH6 exhibit TMZ tolerance after treatment, despite MGMT levels [3,46]. This evidence concerns the gene MGMT and glioma.